Institute for Liver and Digestive Diseases, Hallym University, Chuncheon 24253, Korea.
Cells. 2021 Oct 2;10(10):2634. doi: 10.3390/cells10102634.
Nonalcoholic fatty liver disease (NAFLD) is one of the most common and increasing liver diseases worldwide. NAFLD is a term that involves a variety of conditions such as fatty liver, steatohepatitis, or fibrosis. Gut microbiota and its products have been extensively studied because of a close relation between NAFLD and microbiota in pathogenesis. In the progression of NAFLD, various microbiota-related molecular and cellular mechanisms, including dysbiosis, leaky bowel, endotoxin, bile acids enterohepatic circulation, metabolites, or alcohol-producing microbiota, are involved. Currently, diagnosis and treatment techniques using these mechanisms are being developed. In this review, we will introduce the microbiota-related mechanisms in the progression of NAFLD and future directions will be discussed.
非酒精性脂肪性肝病(NAFLD)是全球最常见且发病率不断上升的肝脏疾病之一。NAFLD 是一个涉及多种疾病的术语,如脂肪肝、脂肪性肝炎或纤维化。由于 NAFLD 与微生物群在发病机制上有密切关系,因此肠道微生物群及其产物已被广泛研究。在 NAFLD 的进展过程中,涉及多种与微生物群相关的分子和细胞机制,包括菌群失调、肠漏、内毒素、胆汁酸肠肝循环、代谢物或产酒精微生物群。目前正在开发利用这些机制的诊断和治疗技术。在这篇综述中,我们将介绍 NAFLD 进展过程中的与微生物群相关的机制,并讨论未来的方向。